❌

Normale Ansicht

Obesity Drug Boom Buoys Ireland’s Pharma Production for Export

17. Februar 2026 um 12:00
Novo Nordisk says it’s investing in production in central Ireland, doing battle with Eli Lilly

Novo Nordisk A/S Wegovy brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. Photographer: George Frey/Bloomberg
❌